Annunziata et al. found that ovarian cancer patients with tumors expressing low levels of the pro-apoptotic molecule caspase 8 showed shorter overall survival compared with those with high caspase 8 expression [76, 77]. This evidence concerns the gene CASP8 and ovarian carcinoma.